According to HealthEquity's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.82658. At the end of 2024 the company had a P/S ratio of 6.64.
Year | P/S ratio | Change |
---|---|---|
2024 | 6.64 | 6.03% |
2023 | 6.26 | -20.99% |
2022 | 7.92 | 6.29% |
2021 | 7.45 | 40.62% |
2020 | 5.30 | -46.42% |
2019 | 9.89 | -53.02% |
2018 | 21.1 | 49.28% |
2017 | 14.1 | 19.87% |
2016 | 11.8 | -27.2% |
2015 | 16.2 | 16% |
2014 | 13.9 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
FirstCash FCFS | 1.64 | -75.97% | ๐บ๐ธ USA |
Amerco UHAL | 2.19 | -67.97% | ๐บ๐ธ USA |
Green Dot GDOT | 0.3194 | -95.32% | ๐บ๐ธ USA |